Background and Purpose-In the United States and elsewhere, stroke performance measures have been developed to monitor and improve the quality of care. The process by which these measures are developed, implemented, and evaluated is complex, evolving, and not widely understood. We review the methodological development of stroke performance measures in the United States. Methods-A literature search identified articles that addressed the development and endorsement of performance measures for stroke care. Emphasis was given to articles specific to acute stroke, but when these were lacking, other cardiovascular diseases were included. Results-Ten process-based performance measures relevant to acute hospital-based stroke care have now been developed and endorsed. These measures include intravenous thrombolysis, deep vein thrombosis prophylaxis, dysphagia screening, stroke education, and discharge-related medications and assessments. There are currently at least 5 major US-based stroke quality improvement programs implementing stroke measures. Data indicate that rapid improvements in the quality of stroke care can be induced by the systematic collection and evaluation of stroke performance measures. However, current stroke measures are relatively limited, addressing only inpatient care and mostly patients with ischemic stroke. Conclusions-Stroke quality improvement is still in its early stages, but data suggest that large-scale improvements in stroke care can result from the implementation of stroke performance measures. Performance measures that address multidisciplinary stroke unit care, outpatient-based care, and patient-oriented outcomes such as functional recovery should be considered. Ongoing challenges relevant to stroke quality improvement include the role of public reporting and the need to link better stroke care to improved patient outcomes. (Stroke. 2010;41:1573-1578.)
H ealthcare systems throughout the world face the vexing problem of improving healthcare quality while at the same time confronted with ever-increasing costs and greater demands for accountability. 1 Over recent years, at least 9 different healthcare organizations and entities in the United States have undertaken initiatives related to measuring and improving the quality of care provided to patients with acute stroke patients (Table 1) . [2] [3] [4] [5] [6] [7] [8] [9] [10] In Canada, stroke quality improvement (QI) efforts, including best practice recommendations for stroke care, have been developed under the auspices of the Canadian Stroke Network and the Heart and Stroke Foundation of Canada. 11 A large part of these initial efforts have been dedicated to determining how to measure the quality of stroke care. [12] [13] [14] This has involved the development and promulgation of performance measures designed to measure specific aspects of the structure, processes, and outcomes of acute stroke care. Ideally, these performance measures should represent measureable and actionable interventions that are supported by evidence-based clinical guidelines. 11, 15, 16 The processes by which performance measures are developed, endorsed, implemented, and evaluated is complex, multifaceted, evolving and not well understood by many healthcare professionals. The degree to which the promulgation of performance measures in local, regional, and national QI initiatives has resulted in measureable improvements in quality of care, as defined by those measures, is reasonably well established. However, whether the public reporting of performance mea-sure data is the most appropriate approach for comparing the quality of care across healthcare entities remains controversial, and concerns have been raised about the unintended consequences of this approach. 17, 18 The objectives of this review article are: (1) to define quality, quality metrics, and performance measures; (2) to review the recommendations for developing performance measures for cardiovascular disease and stroke; and (3) to describe the current stroke performance measures developed for use in the United States.
Definitions of Healthcare Quality, Quality Metrics, and Performance Measures
Defining healthcare quality is an inherently complex task that over the years has involved numerous organizations and agencies that have often had different perspectives and competing interests. Given the complexity of this task, it is not surprising that the language used to describe healthcare quality and quality-related measures is often confusing involving numerous terms and definitions. Over recent years, considerable efforts have been devoted to standardizing definitions. The most comprehensive framework currently proposed for developing quality metrics and performance measures for cardiovascular diseases is described in a 2008 report from the American College of Cardiology/American Heart Association (ACC/AHA) Task Force on Performance Measures. 19 This Task Force was charged with developing performance measures for cardiovascular disease to promote the implementation of clinical guidelines. The task force defined quality metrics as "any objective measure that has been developed to support self-assessment and quality improvement at the provider, hospital, and/or health care system level." 19 They also restricted the use of the term performance measure to those quality metrics selected by the Task Force that have "attributes that render them suitable for public reporting, and other forms of accountability, including direct comparisons between different institutions and health care providers, and possibly pay for performance." 19 These ACC/ AHA-endorsed performance measures are developed using a methodological framework which includes a process for public comment and peer review, and may involve the collaboration of other organizations such as the Joint Commission (TJC), Physicians Consortium for Performance Improvement (PCPI), Center for Medicare and Medicaid Services (CMS), and the National Quality Forum (NQF). 19 Quality metrics, including performance measures, can be classified into 4 groups: process, structure, outcome, and efficiency measures. 14 Process measures illuminate the complicated processes of delivering health care and describe specific actions associated with healthcare delivery. 14, 20 The majority of currently endorsed performance measures for cardiovascular disease and stroke are process-based. Structural measures focus on the characteristics of the resources in the healthcare system, including institutional capacity (eg, The consortium partners with physician groups to provide physician leadership for performance measure development and maintenance American Academy of Neurology (AAN) Stroke quality initiatives and endorsement of measurement sets 5, 6 Participates in the work of the PCPI and partners on the hospital size), system resources (eg, stroke units, strokespecific care protocols, availability of specialists), and system characteristics (eg, teaching status, QI participation). 20 The number of structural measures tends to be limited and their main disadvantage is that many are not readily amenable to modification or improvement. Outcome measures focus on the end results of care or the effect of the care process on the health and well-being of patients and populations. 14, 20 Outcome measures should reflect outcomes that are judged to be important to the patient-so-called patient-oriented or patient-centered outcomes-which include death, disability, functional status, and quality of life. 14 Because stroke can result in lifelong severe disabilities, outcomes measures that address long-term functional status and quality of life are particularly relevant. Efficiency measures are designed to incorporate both the resources expended as well as outcomes. 21 Despite their potential value in producing a more efficient and equitable healthcare system, efficiency-based performance measures are few in number. Quality metrics and performance measures typically focus on processes of care derived from specific recommendations in clinical guidelines. 11, 15, 16 Quality metrics should have sufficient evidence that failure to provide the recommended care or action is likely to result in suboptimal patient outcomes; for example, failure to provide an eligible patient with ischemic stroke with an antithrombotic agent at discharge results in an increased risk of stroke recurrence. Compliance with quality metrics therefore implies that the patient's life can be extended or enhanced. Although some quality metrics do not meet the ACC/AHA criteria for performance measures, a given quality metric can become a performance measure if further research and/or field testing provides evidence that it meets the ACC/AHA standard and is selected by the ACC/AHA Task Force or other organizations. 19 The promotion of a quality metric to a performance measure should involve the consideration of several factors, including the degree to which healthcare providers understand what the measure means, the degree to which healthcare providers can directly influence the measure, the measure's reliability and accuracy, and the feasibility of data collection. 22 Although the ACC/AHA Task Force uses the term quality metrics to describe the broad range of quality-related measures, it should be noted that in practice, these measures are often referred to by several other terms, including quality measures, reporting measures, quality improvement measures, and test measures. For example, the AHA-sponsored Get With The Guidelines-Stroke (GWTG-Stroke) program uses the terms achievement measures, quality measures, and reporting measures to describe its metrics. 4 Compliance with these various metrics are used by GWTG to recognize different levels of performance among participating hospitals, which may include performance measures selected using the ACC/AHA Task Force's methodology.
Recommendations for the Development of Performance Measures for Cardiovascular Disease and Stroke
Although formal efforts to measure the quality of health care date back to the Victorian era and beyond, 23 efforts to systematically conceptualize, define, and measure quality of health care for cardiovascular disease and stroke is a relatively recent undertaking. 12 In 2000, the ACC/AHA first published a report on measuring and improving the quality of care for cardiovascular disease and stroke. 14 This report addressed the methodological challenges of measuring healthcare quality and provided candidate quality measures for acute myocardial infarction, heart failure, and stroke. The reader is referred to the original publication for further details, but examples of proposed process measures for stroke included specific clinical evaluations (brain imaging, electrocardiography), acute therapy (tissue plasminogen activator, aspirin), preventive therapy (antithrombotic therapy and education), and having a functional assessment/rehabilitation plan. 14 Given the documented benefits of coordinated stroke care, 24,25 the proposed structural measures included the presence of a designated stroke unit and a multidisciplinary stroke team. 7 Examples of stroke-specific outcome measures included the prevention of complications (pneumonia, deep vein thrombosis), secondary prevention (recurrent stroke, myocardial infarction), and restoration of function (disability and quality of life). 14 Importantly, this report also addressed the issue of when outcomes should be measured relative to the delivery of stroke care, concluding that stroke-related outcomes should be measured 1 month after discharge from the acute care setting. This time period was chosen because the bulk of stroke recovery occurs within 1 to 3 months and outcomes beyond 1 month are more difficult to ascribe to the care provided during the acute hospitalization. 14 At about the same time as the 2000 ACC/AHA report, Holloway and colleagues convened a panel of 16 multidisciplinary stroke experts to identify and rate hospital-based acute stroke performance measures. 12 A total of 44 measures were rated on the following 6 dimensions: validity, feasibility, impact on outcomes, room for improvement, plausibility, and overall rating. The process identified several highly rated measures, including antithrombotics, anticoagulants, carotid imaging, and the use of stroke units. The study found that the performance measures with the most room for improvement were also those that were the most difficult to measure, highlighting the limitations of current information sources and the need to develop better data collection methods.
A subsequent 2005 ACC/AHA report expanded on the conceptual framework and process described in the initial 2000 ACC/AHA report. 22 The new report detailed a 3-phase process for developing and implementing performance measures. The phases include (1) identification of candidate measures; (2) formal evaluation of the accuracy and feasibility of the measures; and (3) reporting and implementation mechanisms. 22 
Current Stroke Performance Measures
Over the past 5 years, there have been considerable efforts undertaken in the United States to develop common stroke performance measures that can be used by different accreditation and evaluation organizations. This effort was driven in part by healthcare providers who, participating in multiple QI projects, wanted to avoid duplicate data collection efforts. In 2003, TJC in collaboration with AHA/ASA began developing performance measures for the Certification for Primary Stroke Centers based on recommendations of the Brain Attack Coalition and other evidence-based guidelines. 15, 16 Because many Primary Stroke Center sites were also participating in the GWTG-Stroke program or the Centers for Disease Control and Prevention (CDC) Paul Coverdell Registry, the effort was expanded to include all 3 programs. The Stroke Performance Measure Consensus Group, comprising representatives from TJC, AHA/ASA, and the CDC, was established to align data element definitions and develop common guidelines for data abstraction across the 3 measurement sets.
The resulting 10 harmonized consensus stroke performance measures (current as of December 2009) are shown in Table 2 . These 10 measures are limited to process measures that apply to acute hospital care and are mostly relevant to patients with ischemic stroke. Obviously, the current set of measures does not include all worthwhile clinical interventions; several interventions with substantial evidence supporting their role in stroke care (eg, carotid endarterectomy, hypertension control, use of stroke units) are challenging to measure or define in the acute stroke setting and are therefore not included. Although every effort was made to operationalize each measure in the exact same manner, there are some noted that the refinement of these measures is an ongoing process and so further changes can be expected. Because of the central role played by the NQF as an independent arbiter of quality measurement, and the policies of the TJC relating to external validation of performance measures, the 10 measures were submitted to the NQF in response to a call for stroke measures issued by the CMS in 2007. In July 2008, 8 of the measures were endorsed by the NQF. 26 Smoking cessation was not endorsed as a separate stroke measure because the NQF already endorsed a global smoking measure that applies to all hospitalized patients, and dysphagia screening was not endorsed due to limited evidence that the measure improves outcomes and concerns over the validity of the screening tools.
Importantly, the CMS has announced their intention to include the 8 NQF-endorsed stroke measures as part of the Reporting Hospital Quality Data for Annual Payment Update (RHQDAPU) initiative beginning with inpatient discharges in Fiscal Year 2011. 27 Hospitals must participate in the RHQDAPU and report these measures in 2011 to receive full Medicare payment in Fiscal Year 2012. 28 Current CMS publicly reported performance measures are available to consumers on the Hospital Compare web site. 29 Their inclusion in RHQDAPU is an important milestone; data on the quality of acute stroke care will now be available from almost all US acute hospitals and not just those participating in voluntary QI programs. Additionally, several analogous stroke measures that are reported at the provider level rather than institutional level have been constructed and endorsed by the NQF for use in the CMS Physician Quality Reporting Initiative (PQRI) program, an incentive pay-for-reporting program for health professionals. 10 The inclusion of stroke performance measures in QI programs such as the Paul Coverdell National Acute Stroke Registry 3 and the GWTG-Stroke Program 4 plays an essential role by allowing for the measurement and monitoring of quality of care. There is now increasingly good evidence from initiatives such as the Coverdell Registry, 30 GWTG-Stroke, 31 and other QI programs 32 that a process based on the systematic collection and evaluation of stroke performance measures can result in rapid improvement in the quality of stroke care delivered by hospitals. For example, recent data from GWTG-Stroke measured adherence to 7 of the 10 currently endorsed stroke performance measures in Ͼ322 000 patients discharged with ischemic stroke or transient ischemic attack from 790 hospitals nationally. 31 The authors found statistically significant and clinically meaningful improvements in all measures over a 5-year period since the program started in 2003 with absolute increases ranging from 3.2% to 30.7%. Other examples include a 1-year QI intervention conducted by a prototype Coverdell Registry in 13 Michigan hospitals, which found significant improvements in 5 of 16 measures targeted. 33 Finally, although this review is focused on the development and use of stroke performance measures in North America, it should be noted that similar efforts to develop stroke measures to promote QI exist in several other countries, including the United Kingdom, 34 Germany, 35 Sweden, 36 Denmark, 37 Australia, 38 and New Zealand. 39 A full discussion of these programs is beyond the scope of this article.
Limitations
The current stroke performance measures have several limitations. First, the current metrics are mostly limited to process measures that address the care of patients with ischemic stroke in acute hospital-based settings. Further efforts are required to expand the scope of performance measures to include ambulatory-based settings as well as other subtypes (ie, hemorrhagic stroke). Second, there is a pressing need for research to demonstrate a direct link between better adherence to stroke performance measures and improved patient-oriented outcomes. Finally, like with all quality measures, there are inherent limitations to using a limited number of specific metrics to defining the complex trait of healthcare quality.
Conclusions
Despite the considerable progress made to date to develop methodological standards for quality metrics and performance measures, continuing concerns about the process have led to the recommendation to set up a government-sponsored agency to develop and oversee national standards for the development and public reporting of quality-of-care measures. 40 A recent Institute of Medicine report on performance measurement came to a similar conclusion, recommending the establishment of a new independent board, the National Quality Coordination Board, housed within the US Department of Health and Human Services, to provide coordination and financial support to strengthen ongoing standards and activities in both the public and private sectors. 41 Although stroke QI programs are still in their early stages, data indicate that large-scale changes in quality of care can be induced by the systematic collection and evaluation of stroke quality data. However, the current stroke performance measures are limited to process measures and are applicable to acute hospital-based care only; measures that address organized multidisciplinary care, outpatient-based care, and patient-oriented outcomes are clearly needed. Other ongoing challenges to the continued development and enhancement of stroke performance measures include the role of public reporting and the need to develop more evidence linking better quality of care to improved patient-oriented outcomes. Paul Coverdell 国家急性卒中登记 [3] "跟着指南走 -卒中"项目 [4] 提高医疗保健质量医生协会 (PCPI) [5] 倡议提高脑卒中医疗保健质量，及评估 项目认可 [5, 6] 脑卒中医疗质量提高研究倡议 (QUERI) [7] 评测和报告质量的国家统一标准 [5, 8] 心脏病 / 卒中评估项目 [9] PQRI [10] RHQDAPU ，保障医疗保健质量的评定和监测，发 挥了重要作用。越来越多来自 Coverdell 登记 [30] 、 "跟 着指南走 -卒中"项目 [31] 
